Truncated AUC for long half-life drugs [Design Issues]

posted by Dr Andrew Leary – Ireland, 2009-07-01 18:57 (6208 d 19:48 ago) – Posting: # 3920
Views: 4,116

Helmut et al - Greetings from Ireland where it is pissing rain as usual (and also very green)!

The latest draft guidelines seem to suggest that it should no longer be necessary to measure out beyond 72 hours in BE studies where the drug has a long half-life (though I note that "long half-life" is not defined). Do you know whether or not practice has changed yet, or are drug companies and CROs still sampling out beyond 72 hours "just to be safe"? :-P

Kind regards

Andrew Leary

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
254 visitors (0 registered, 254 guests [including 21 identified bots]).
Forum time: 14:46 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5